Nettet29. nov. 2024 · Blueprint Medicines Inc. is paying nearly half a billion dollars to buy a San Diego-based cancer startup called Lengo Therapeutics. Blueprint (Nasdaq: BPMC) has agreed to pay Lengo $250 million in ... NettetAbout Us Our Company Contact Our Pipeline Pipeline Clinical Trials Our Approach Integrated Discovery Engine Supporting Publications Investors & Media Investor Home News & Events Stock Information Financials & Filings Corporate Governance Investor Resources Careers Why Zentalis? Job Opportunities
Blueprint Medicines shells out nearly $500M for cancer startup
Nettet30. nov. 2024 · San Diego oncology startup Lengo Therapeutics is being acquired by publicly traded Blueprint Medicines for $250 million in cash — and possibly more if it hits certain milestones — to push forward... Nettetannounced the launch of Lengo Therapeutics, Inc. (“Lengo”), a biopharmaceutical company focused on the discovery and development of novel treatments targeting driver mutations in oncology. “Company formation is one of our core activities at Frazier, and Jubilant has been a key part of several of our husband walked out of detox
Lengo Therapeutics LinkedIn
Nettet30. des. 2024 · As previously disclosed, under the terms of the agreement, Blueprint Medicines acquired Lengo Therapeutics for $250 million in cash plus up to $215 million in additional potential payments... Nettet30. nov. 2024 · Lengo Therapeutics plans to file an investigational new drug application to the FDA to begin clinical studies on LNG-451 in December 2024. The acquisition of Lengo Therapeutics will also... NettetAddress: 3525 Del Mar Heights Rd Ste 1927 San Diego, CA, 92130-2199 United States See other locations Phone: Website: www.blueprintmedicines.com Employees (all sites): Actual Revenue: Modelled Year Started: Incorporated: ESG ranking: ESG industry average: What is D&B's ESG Ranking? Is this your business? husband wakes up angry